Atlas Labs Bio products are sold for laboratory research use only — not for human or animal consumption, and not intended to diagnose, treat, cure, or prevent any disease. Must be handled only by qualified researchers, in accordance with all applicable laws. See the full Research Disclaimer page for complete terms.

FOXO4-DRI

≥98% Purity Research Use Only

$119.99

FOXO4-DRI is a synthetic D-retro-inverso peptide designed to interfere with the interaction between the FOXO4 and p53 proteins, studied in cellular senescence research. Supplied as a lyophilized powder for laboratory research use only.

SKU: ATL-PEP-FOXO4DRI-10MG Category:

Description

What is FOXO4-DRI?

FOXO4-DRI is a synthetic peptide built from D-amino acids in retro-inverso order (CAS 2460055-10-9, molecular formula C228H388N86O64, molecular weight 5358.05 g/mol). It was designed to disrupt the interaction between the transcription factor FOXO4 and the tumor suppressor protein p53.[1]

Research background

FOXO4-DRI was described in a 2017 study in Cell, which reported that disrupting the FOXO4-p53 interaction caused p53 nuclear exclusion and apoptosis selectively in senescent cells, in cell and mouse models.[1] A 2025 follow-up study identified the disordered p53 transactivation domain as the target of FOXO4 and of FOXO4-DRI.[2]

Format and documentation

Atlas Labs Bio supplies FOXO4-DRI as a white to off-white lyophilized powder in a sealed 10 mg glass vial. Third-party certificates of analysis for Atlas Labs Bio products are published in the COA Library.

Storage: Store at 2-8°C.

Frequently asked questions

What does “DRI” mean?

D-retro-inverso: the peptide is made from D-amino acids in reversed sequence order, a design commonly used to make peptides more resistant to enzymatic breakdown.

What interaction does FOXO4-DRI target?

The interaction between FOXO4 and p53.[1][2]

Can FOXO4-DRI be used by people?

No. Atlas Labs Bio products are sold strictly for laboratory research use and are not for human or animal consumption.

References

  1. “Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging.” Cell, 2017. PMID 28340339.
  2. “The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.” Nature Communications, 2025. PMID 40593617.

Reviews

There are no reviews yet.

Be the first to review “FOXO4-DRI”

Your email address will not be published. Required fields are marked *

Properties

CAS Number
2460055-10-9
Synonyms
Proxofim, FOXO4 D-Retro-Inverso peptide
Molecular Formula
C228H388N86O64
Molecular Weight
5358.05 g/mol
Physical Appearance
White to off-white lyophilized powder
Terms
Atlas Labs Bio products are sold for laboratory research use only — not for human or animal consumption, and not intended to diagnose, treat, cure, or prevent any disease. Must be handled only by qualified researchers, in accordance with all applicable laws. See the full Research Disclaimer page for complete terms.

Certificate Of Analysis

Current Batch

The certificate of analysis for the current batch is being prepared and will be published here.